[1]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.-WO2022/133038,2022,A1Locationinpatent:Paragraph00302
[2]CurrentPatentAssignee:MIRATITHERAPEUTICS,INC.-WO2022/133038,2022,A1Locationinpatent:Paragraph00302
1423026-01-0
1186688-54-9
955028-83-8
1461706-48-8
1803600-22-7
1052713-79-7
1909305-73-2 | 1-(3-fluoro-5-methoxyphenyl)propan-2-amine hydrochloride | AA01C211 | MFCD29047566
1268842-79-0 | 1-(tert-Butoxycarbonyl)cyclopropanecarboxylic acid | AA01C25P | MFCD22372629
69193-55-1 | 3-Methylidene-1-phenylazetidin-2-one | AA01C29Y | MFCD27927471
1955554-02-5 | 2-chloro-3-fluoropyridin-4-amine hydrochloride | AA01C2EE | MFCD29054991
1602185-22-7 | 1-[(4-bromo-2-chlorophenyl)methyl]-1H-pyrazol-4-amine | AA01C2IH | MFCD29055037
78773-77-0 | tert-butyl 2-(cyclopropylamino)propanoate | AA01C2NB | MFCD20680093
1909348-50-0 | tert-Butyl 5-(chlorosulfonyl)-1,2-oxazole-3-carboxylate | AA01C2R5 | MFCD29906804
1909313-38-7 | 3-cyclopropyl-3-methoxybutan-2-amine | AA01C2VW | MFCD29762756
1152504-06-7 | 3-Methyl-1-p-tolyl-1h-pyrazole-4-carbaldehyde | AA01C301 | MFCD11180095
1909326-00-6 | [(2-bromoethoxy)methyl]cyclobutane | AA01C34G | MFCD29060348